Lung disease caused by ABCA3 mutations

Thorax

Volumn 72, Issue 3, 2017, Pages 213-220

  Kröner, Carolin ^a   Wittmann, Thomas ^a   Reu, Simone ^b   Teusch, Veronika ^a   Klemme, Mathias ^a   Rauch, Daniela ^a   Hengst, Meike ^a   Kappler, Matthias ^a   Cobanoglu, Nazan ^c   Sismanlar, Tugba ^d   Aslan, Ayse T ^d   Campo, Ilaria ^e   Proesmans, Marijke ^f   Schaible, Thomas ^g   Terheggen Lagro, Susanne ^h   Regamey, Nicolas ⁱ   Eber, Ernst ^j   Seidenberg, Jürgen ^k   Schwerk, Nicolaus ^l   Aslanidis, Charalampos ^m   Lohse, Peter ⁿ   Brasch, Frank ^o   Zarbock, Ralf ^a   Griese, Matthias ^a   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c ANKARA UNIVERSITY   (Turkey)

^d GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^e UNIVERSITY OF PAVIA   (Italy)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h EMMA CHILDREN S HOSPITAL   (Netherlands)

ⁱ CHILDREN S HOSPITAL   (Switzerland)

^j MEDICAL UNIVERSITY OF GRAZ   (Austria)

^k UNIVERSITY OF OLDENBURG   (Germany)

^l HANNOVER MEDICAL SCHOOL   (Germany)

^m UNIVERSITY OF REGENSBURG   (Germany)

ⁿ NONE   (Germany)

^o Bielefeld Academic Teaching Hospital   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; LUNG SURFACTANT; STEROID; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; ABC TRANSPORTER; ABCA3 PROTEIN, HUMAN;

ABCA3 GENE; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG RESPONSE; EUROPEAN; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIATION; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LONG TERM SURVIVAL; LUNG DISEASE; LUNG LAVAGE; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY; X-RAY COMPUTED TOMOGRAPHY; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; CONSANGUINITY; DIAGNOSTIC IMAGING; ELECTRON MICROSCOPY; GENETICS; GENOTYPE; IMMUNOHISTOCHEMISTRY; INFANT; INTERSTITIAL LUNG DISEASE; MORTALITY; MUTATION; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; SURVIVAL ANALYSIS;

ADOLESCENT; ADULT; ATP-BINDING CASSETTE TRANSPORTERS; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; CONSANGUINITY; DIAGNOSTIC IMAGING; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LUNG DISEASES, INTERSTITIAL; MALE; MICROSCOPY, ELECTRON; MUTATION; PHENOTYPE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84981554535     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-208649     Document Type: Article

References (33)

1. Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 2001;11:1156-66.
2. Allikmets R, Gerrard B, Hutchinson A, et al. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. Hum Mol Genet 1996;5:1649-55.
3. Connors TD, Van Raay TJ, Petry LR, et al. The cloning of a human ABC gene (ABC3) mapping to chromosome 16p13.3. Genomics 1997;39:231-4.
4. Yamano G, Funahashi H, Kawanami O, et al. ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett 2001;508:221-5.
5. Ban N, Matsumura Y, Sakai H, et al. ABCA3 as a lipid transporter in pulmonary surfactant biogenesis. J Biol Chem 2007;282:9628-34.
6. Parappil H, Al Baridi A, ur Rahman S, et al. Respiratory distress syndrome due to a novel homozygous ABCA3 mutation in a term neonate. BMJ Case Rep 2011;2011. pii: bcr1020103427.
7. Wambach JA, Casey AM, Fishman MP, et al. Genotype-phenotype correlations for infants and children with ABCA3 deficiency. Am J Resp Crit Care Med 2014;189:1538-43.
8. Flamein F, Riffault L, Muselet-Charlier C, et al. Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. Human Mol Genet 2012;21:765-75.
9. Bullard JE, Wert SE, Whitsett JA, et al. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 2005;172:1026-31.
10. Campo I, Zorzetto M, Mariani F, et al. A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant. Respir Res 2014;15:43.
11. Epaud R, Delestrain C, Louha M, et al. Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations. Eur Respir J 2014;43:638-41.
12. Coghlan MA, Shifren A, Huang HJ, et al. Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations. BMJ Open Respir Res 2014;1:e000057.
13. Brasch F, Schimanski S, Mühlfeld C, et al. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Resp Crit Care Med 2006;174:571-80.
14. Shulenin S, Nogee LM, Annilo T, et al. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004;350:1296-303.
15. Carrera P, Ferrari M, Presi S, et al. Null ABCA3 in humans: large homozygous ABCA3 deletion, correlation to clinical-pathological findings. Pediatr Pulmonol 2014;49:E116-120.
16. Ciantelli M, Ghirri P, Presi S, et al. Fatal respiratory failure in a full-term newborn with two ABCA3 gene mutations: a case report. J Perinatol 2011;31:70-2.
17. Piersigilli F, Peca D, Campi F, et al. New ATP-binding cassette A3 mutation causing surfactant metabolism dysfunction pulmonary type 3. Pediatr Int 2015;57:970-4.
18. Jackson T, Wegner DJ, White FV, et al. Respiratory failure in a term infant with cis and trans mutations in ABCA3. J Perinatol 2015;35:231-2.
19. Tan JK, Murray C, Schultz A. ABCA3 lung disease in an ex 27 week preterm infant responsive to systemic glucocorticosteroids. Pediatr Pulmonol 2016;51:E1-3.
20. Hallik M, Annilo T, Ilmoja ML. Different course of lung disease in two siblings with novel ABCA3 mutations. Eur J Pediatr 2014;173:1553-6.
21. Doan ML, Guillerman RP, Dishop MK, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008;63:366-73.
22. Choi Y, Sims GE, Murphy S, et al. Predicting the functional effect of amino acid substitutions and indels. PLoS ONE 2012;7:e46688.
23. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073-81.
24. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-9.
25. Tafel O, Latzin P, Paul K, et al. Surfactant proteins SP-B and SP-C and their precursors in bronchoalveolar lavages from children with acute and chronic inflammatory airway disease. BMC Pulm Med 2008;8:6.
26. Kröner C, Reu S, Teusch V, et al. Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients. Eur Respir J 2015;46:197-206.
27. Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007;176:1120-8.
28. Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246:697-722.
29. Thavagnanam S, Cutz E, Manson D, et al. Variable clinical outcome of ABCA3 deficiency in two siblings. Pediatr Pulmonol 2013;48:1035-8.
30. Hildebrandt J, Yalcin E, Bresser HG, et al. Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis. Orphanet J Rare Dis 2014;9:171.
31. Hayes D Jr, Lloyd EA, Fitch JA, et al. ABCA3 transporter deficiency. Am J Respir Crit Care Med 2012;186:807.
32. Ryan NJ. Ataluren: first global approval. Drugs 2014;74:1709-14.
33. Wainwright CE, Elborn JS, Ramsey BW. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med 2015;373:1783-4.